Add Company
Join Now

Isomerase Revenue and Competitors

License our Company Data API

Cambridge, CA UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Isomerase's estimated annual revenue is currently $8M per year.(i)
  • Isomerase's estimated revenue per employee is $229,714

Employee Data

  • Isomerase has 35 Employees.(i)
  • Isomerase grew their employee count by 0% last year.

Isomerase's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Isomerase?

Isomerase is an innovation partner supporting companies with biotechnology services, including microbial strain development and fermentation process development to produce anything from natural products to enzymes, agricultural and consumer products; sustainably, cost effectively and at scale.

keywords:biotechnology, bioengineering, bioprocess development, enzyme engineering

N/A

Total Funding

35

Number of Employees

$8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Isomerase News

2022-04-06 - Fatty acid oxidation enzyme ?3, ?2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients

Fatty acid oxidation enzyme ?3, ?2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate...

2022-03-22 - Naturally occurring deamidated triosephosphate isomerase is ...

Human triosephosphate isomerase (HsTIM) is a central glycolytic enzyme and is overexpressed in cancer cells with accelerated glycolysis.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.7M35-58%$65M
#2
$4.1M35-33%N/A
#3
$3.5M3521%N/A
#4
$5.9M356%N/A
#5
$9.1M35-42%N/A